Trials / Sponsors / Shanghai Best-Link Bioscience, LLC
Shanghai Best-Link Bioscience, LLC
Industry · 5 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Clinical Study for the Efficacy and Safety of BL0020 Injection in Patients With Small Cell Lung Cancer Trans Small Cell Carcinoma of Lung | Phase 1 / Phase 2 | 2026-03-27 |
| Not Yet Recruiting | A Study of Single Dose of BL0175 in Postmenopausal Women Postmenopausal Women | Phase 1 | 2026-01-26 |
| Recruiting | A Study of BL0175 Injection in Postmenopausal Female Adults With HR-positive, Locally Advanced or Metastatic C Breast Cancer, Ovarian Cancer, Endometrial Cancer | Phase 1 | 2025-03-10 |
| Recruiting | A Phase I Study to Assess the Safety and Tolerability of BL0006 for Patients With Advanced Solid Tumours Advanced Solid Tumor | Phase 1 | 2024-01-03 |
| Unknown | Phase I Study of BL0020, a Novel Anti-tumor Drug, in Adult Subjects With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2023-10-24 |